Literature DB >> 6980419

Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+.

A M Krensky, C S Reiss, J W Mier, J L Strominger, S J Burakoff.   

Abstract

Human allospecific cytotoxic T lymphocyte lines were established by weekly stimulation of peripheral blood lymphocytes with allogeneic Epstein-Barr virus-transformed lymphoblastoid cell lines in the presence of interleukin 2. The cytotoxic T lymphocyte lines were stimulated by either JY (which expresses HLA-A,B and -DR) or Daudi (which expresses HLA-DR but not -A,B antigens). Specificity of the effector cell lines was determined by antibody blocking and by patterns of cytolysis against a panel of target cell lines. The phenotype of the effector cells was identified by both negative (antibody and complement lysis) and positive (fluorescence-activated cell sorter) selection. The anti-JY lines only recognized targets bearing HLA-A2, B7 antigens and were composed exclusively of OKT4-8+ effector cells. The anti-Daudi lines, on the other hand, specifically recognized targets bearing DR6 and eventually contained only OKT4+8- cells. Thus, stimulation by Daudi cells can result in the generation of OKT4+ CTL lines that are allospecific for DR6 antigen.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6980419      PMCID: PMC346194          DOI: 10.1073/pnas.79.7.2365

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Assay for Epstein-Barr virus based on stimulation of DNA synthesis in mixed leukocytes from human umbilical cord blood.

Authors:  J Robinson
Journal:  J Virol       Date:  1975-05       Impact factor: 5.103

2.  Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association.

Authors:  T A Springer; J F Kaufman; L A Siddoway; D L Mann; J L Strominger
Journal:  J Biol Chem       Date:  1977-09-10       Impact factor: 5.157

3.  Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.

Authors:  W H West; G B Cannon; H D Kay; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

4.  Derect lymphocyte-mediated cytotoxicity as an assay of presensitisation.

Authors:  M R Garovoy; V Franco; D Zschaeck; C B Carpenter; T B Strom; J P Merrill
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

5.  Cell-mediated cell lysis in vitro: genetic control of killer cell production and target specificities in the mouse.

Authors:  M Nabholz; J Vives; H M Young; T Meo; V Miggiano; A Rijnbeek; D C Shreffler
Journal:  Eur J Immunol       Date:  1974-05       Impact factor: 5.532

6.  Fluorescence activated cell sorting.

Authors:  W A Bonner; H R Hulett; R G Sweet; L A Herzenberg
Journal:  Rev Sci Instrum       Date:  1972-03       Impact factor: 1.523

7.  Histocompatibility antigens controlled by the I region of the murine H-2 complex. II. K/D region compatibility is not required for I-region cell-mediated lymphocytotoxicity.

Authors:  J Klein; C L Chiang; V Hauptfeld
Journal:  J Exp Med       Date:  1977-02-01       Impact factor: 14.307

8.  Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.

Authors:  H Cantor; E A Boyse
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

9.  Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.

Authors:  P Billings; S Burakoff; M E Dorf; B Benacerraf
Journal:  J Exp Med       Date:  1977-05-01       Impact factor: 14.307

10.  Induction of cytotoxic T lymphocytes against I-region-coded determinants: in vitro evidence for a third histocompatibility locus in the mouse.

Authors:  H Wagner; D Götze; L Ptschelinzew; M Röllinghoff
Journal:  J Exp Med       Date:  1975-12-01       Impact factor: 14.307

View more
  61 in total

1.  The expansion of human gammadelta T cells in response to Daudi cells requires the participation of CD4+ T cells.

Authors:  J D Fayen; M L Tykocinski
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

2.  CD4 cytotoxic and dendritic cells in the immunopathologic lesion of Sjögren's syndrome.

Authors:  G Xanthou; N I Tapinos; M Polihronis; I P Nezis; L H Margaritis; H M Moutsopoulos
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

Review 3.  The physiological role of cytotoxic CD4(+) T-cells: the holy grail?

Authors:  V Appay
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

Review 4.  CD8⁺ T Cell-Independent Immune-Mediated Mechanisms of Anti-Tumor Activity.

Authors:  G Elizabeth Pluhar; Christopher A Pennell; Michael R Olin
Journal:  Crit Rev Immunol       Date:  2015       Impact factor: 2.214

5.  CD4 T cells mediate killing during persistent gammaherpesvirus 68 infection.

Authors:  Kathleen A Stuller; Emilio Flaño
Journal:  J Virol       Date:  2009-02-25       Impact factor: 5.103

6.  Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseases.

Authors:  J L Strominger
Journal:  J Clin Invest       Date:  1986-05       Impact factor: 14.808

7.  The acquired immunodeficiency syndrome (AIDS).

Authors:  F S Rosen
Journal:  J Clin Invest       Date:  1985-01       Impact factor: 14.808

8.  Human lymphocyte function-associated antigens.

Authors:  A M Krensky; F Sanchez-Madrid; T A Springer; S J Burakoff
Journal:  Surv Immunol Res       Date:  1984

9.  HLA antigen expression in enteropathy associated T cell lymphoma.

Authors:  M Ashton-Key; N Singh; L X Pan; M E Smith
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

10.  Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.

Authors:  T A Waldmann; W C Greene; P S Sarin; C Saxinger; D W Blayney; W A Blattner; C K Goldman; K Bongiovanni; S Sharrow; J M Depper
Journal:  J Clin Invest       Date:  1984-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.